Hypocretin/orexin and narcolepsy: New basic and clinical insights

Acta Physiologica

Volumn 198, Issue 3, 2010, Pages 209-222

  Nishino, S ^a   Okuro, M ^a   Kotorii, N ^a   Anegawa, E ^a   Ishimaru, Y ^a   Matsumura, M ^a   Kanbayashi, T ^b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cataplexy; Cerebrospinal fluid; Hypocretin; Narcolepsy; Orexin; Rapid eye movement sleep

Indexed keywords

AMPHETAMINE; AMPHETAMINE DERIVATIVE; ANTIDEPRESSANT AGENT; ANTIGEN; AQUAPORIN; CATECHOL METHYLTRANSFERASE; HLA ANTIGEN; IMMUNOSUPPRESSIVE AGENT; MEMBRANE PROTEIN; MODAFINIL; OREXIN; OREXIN 1 RECEPTOR; OREXIN 2 RECEPTOR; OREXIN A; PROTEIN ANTIBODY; PROTEIN AQP4; RECOMBINANT OREXIN; RECOMBINANT PROTEIN; STEROID; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

AUTOIMMUNITY; CATAPLEXY; CELL TRANSPLANTATION; CEREBROSPINAL FLUID LEVEL; CLINICAL TRIAL; CONFERENCE PAPER; DAYTIME SOMNOLENCE; DNA POLYMORPHISM; ELECTROENCEPHALOGRAM; GENE EXPRESSION; GENE MUTATION; GENE THERAPY; GENETIC RISK; GENETIC SUSCEPTIBILITY; GUILLAIN BARRE SYNDROME; HIGH RISK PATIENT; HORMONE SUBSTITUTION; HUMAN; HYPOTHALAMUS; MULTIPLE SCLEROSIS; MYELOOPTIC NEUROPATHY; NARCOLEPSY; NERVE CELL NECROSIS; NONHUMAN; NONREM SLEEP; PARANEOPLASTIC SYNDROME; PATHOPHYSIOLOGY; PERINATAL PERIOD; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; REM SLEEP;

ANIMALS; CELL DEATH; CIRCADIAN RHYTHM; HUMANS; HYPOTHALAMUS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LIGANDS; NARCOLEPSY; NEUROMYELITIS OPTICA; NEURONS; NEUROPEPTIDES; NEUROTRANSMITTER AGENTS; POLYMORPHISM, GENETIC; SLEEP STAGES;

EID: 75749107802     PISSN: 17481708     EISSN: 17481716     Source Type: Journal    
DOI: 10.1111/j.1748-1716.2009.02012.x     Document Type: Conference Paper

References (89)

1. Adie, J. 1926. Idiopathic narcolepsy: a disease sui generis, with remarks on the mechanism of sleep. Brain 49, 257 306.
2. Aggarwal, B.B. 1992. Comparative analysis of the structure and function of TNF-alpha and TNF-beta. Immunol Ser 56, 61 78.
3. Alaila, S.L. 1992. Life effects of narcolepsy: measures of negative impact, social support and psychological well-being. In : M. Goswanmi, C.P. Pollak, F.L. Cohen, M.J. Thorpy N.B. Kavey (eds) Loss, Grief and Care: Psychosocial Aspects of Narcolepsy. Haworth Press, New York. pp. 1 22.
4. Aldrich, M. Naylor, M. 1989. Narcolepsy associated with lesions of the diencephalon. Neurology 39, 1505 1508.
5. Aldrich, M.S., Chervin, R.D. Malow, B.A. 1997. Value of the multiple sleep latency test (MSLT) for the diagnosis of narcolepsy. Sleep 20, 620 629.
6. Amiry-Moghaddam, M. Ottersen, O.P. 2003. The molecular basis of water transport in the brain. Nat Rev Neurosci 4, 991 1001.
7. Arias-Carrión, O., Murillo-Rodriguez, E., Xu, M., Blanco-Centurión, C., Drucker-Colin, R. Shiromani, P. J. 2004. Transplantation of hypocretin neurons into the pontine reticular formation: preliminary results. Sleep 27, 1465 1470.
8. Baba, T., Nakashima, I., Kanbayashi, T., Konno, M., Takahashi, T., Fujihara, K., MIsu, T., Takeda, A., Shiba, Y., Ogawa, H. Itoyama, Y. 2008. Narcolepsy as an initial manifestation of neuromyelitis optica with anti-aquaporin 4 antibody. J Neurol 256, 287 288.
9. Barker, W. 1948. Studies in epilepsy: personality patterns, situational stress and the symptoms of narcolepsy. Psychosom Med 10, 193 202.
10. Beutler, B. Grau, G.E. 1993. Tumor necrosis factor in the pathogenesis of infectious diseases. Crit Care Med 21, S423 S435.
11. Billiard, M., Laaberki, M.F., Reygrobellet, C., Seignalet, J., Brissaud, L. Besset, A. 1989. Elevated antibodies to streptococcal antigens in narcoleptic subjects. Sleep Res 18, 201.
12. Black, J.L., III., Krahn, L.E., Pankratz, V.S. Silber, M. 2002. Search for neuron-specific and non-neuron-specific antibodies in narcoleptic patients with and without HLA DQB1*0602. Sleep 25, 719 723.
13. Black, J.L., III., Silber, M.H., Krahn, L.E., Avula, R.K., Walker, D.L., Pankratz, V.S., Fredrickson, P.A. Slocumb, N.L. 2005. Studies of humoral immunity to pre-prohypocretin in human leukocyte antigen DQB1*0602- positive narcoleptic subjects with cataplexy. Biol Psychiatry 58, 504 509.
14. Blouin, A.M., Thannickal, T.C., Worley, P.F., Baraban, J.M., Reti, I.M. Siegel, J.M. 2005. Narp immunostaining of human hypocretin (orexin) neurons: loss in narcolepsy. Neurology 65, 1189 1192.
15. Chemelli, R.M., Willie, J.T., Sinton, C.M., Elmquist, J.K., Scammell, T., Lee, C., Richardson, J.A., Williams, S.C., Xiong, Y., Kisanuki, Y., Fitch, T.E., Nakazato, M., Hammer, R.E., Saper, C.B. Yanagisawa, M. 1999. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 98, 437 451.
16. Crocker, A., Espana, R.A., Papadopoulou, M., Saper, C.B., Faraco, J., Sakurai, T., Honda, M., Mignot, E. Scammell, T.E. 2005. Concomitant loss of dynorphin, NARP, and orexin in narcolepsy. Neurology 65, 1184 1188.
17. Dauvilliers, Y., Neidhart, E., Lecendreux, M., Billiard, M. Tafti, M. 2001. MAO-A and COMT polymorphisms and gene effects in narcolepsy. Mol Psychiatry 6, 367 372.
18. Dauvilliers, Y., Arnulf, I. Mignot, E. 2007. Narcolepsy with cataplexy. Lancet 369, 499 511.
19. De Lecea, L., Kilduff, T.S., Peyron, C., Gao, X.-B., Foye, P.E., Danielson, P.E., Fukuhara, C., Battenberg, E.L.F., Gautvik, V.T., Barlett, F.S., Frankel, W.N., Van Den Pol, A.N., Bloom, F.E., Gautvik, K.M. Sutcliffe, J.G. 1998. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci U S A 95, 322 327.
20. Dickstein, J.B., Moldofsky, H., Lue, F.A. Hay, J.B. 1999. Intracerebroventricular injection of TNF-alpha promotes sleep and is recovered in cervical lymph. Am J Physiol 276, R1018 R1022.
21. von Economo, C. 1930. Sleep as a problem of localization. J Nerv Ment Dis 71, 249 259.
22. von Economo, C. 1931. Encephalitis lethargica: its sequelae and treatment translated by K. O. Newman) Oxford University Press, London.
23. Espana, R.A. Scammell, T.E. 2004. Sleep neurobiology for the clinician. Sleep 27, 811 820.
24. Frederickson, S., Carlander, B., Billiard, M. Link, H. 1990. CSF immune variable in patients with narcolepsy. Acta Neurol Scand 81, 253 254.
25. Fujiki, N., Ripley, B., Yoshida, Y., Mignot, E. Nishino, S. 2003. Effects of IV and ICV hypocretin-1 (orexin A) in hypocretin receptor-2 gene mutated narcoleptic dogs and IV hypocretin-1 replacement therapy in a hypocretin ligand deficient narcoleptic dog. Sleep 6, 953 959.
26. Gill, A. 1941. Idiopathic and traumatic narcolepsy. Lancet 240, 474 479.
27. Hallmayer, J., Faraco, J., Lin, L., Hesselson, S., Winkelmann, J., Kawashima, M., Mayer, G., Plazzi, G., Nevsimalova, S., Bourgin, P. et al. 2009. Narcolepsy is strongly associated with the T-cell receptor alpha locus. Nat Genet 41, 708 711.
28. Hohjoh, H., Nakayama, T., Ohashi, J., Miyagawa, T., Tanaka, H., Akaza, T., Honda, Y., Juji, T. Tokunaga, K. 1999. Significant association of a single nucleotide polymorphism in the tumor necrosis factor-alpha (TNF-alpha) gene promoter with human narcolepsy. Tissue Antigens 54, 138 145. (Pubitemid 29410771)
29. Hohjoh, H., Terada, N., Kawashima, M., Honda, Y. Tokunaga, K. 2000. Significant association of the tumor necrosis factor receptor 2 (TNFR2) gene with human narcolepsy. Tissue Antigens 56, 446 448.
30. Honda, Y. 1988. Clinical features of narcolepsy: Japanese experience. In : Y. Honda T. Juji (eds) HLA in Narcolepsy. New York, Springer-Verlag. pp. 24 57.
31. Honda, M., Eriksson, K.S., Zhang, S., Tanaka, S., Lin, L., Salehi, A., Hesla, P.E., Maehlen, J., Gaus, S.E., Yanagisawa, M., Sakurai, T., Taheri, S., Tsuchiya, K., Honda, Y. Mignot, E. 2009. IGFBP3 colocalizes with and regulates hypocretin (orexin). PLoS ONE 4, e4254.
32. ICSD-2 (ed 2005. ICSD-2-International classification of sleep disorders, 2nd edn, Diagnostic and Coding Manual. American Academy of Sleep Medicine, Westchester, IL.
33. Juji, T., Satake, M., Honda, Y. Doi, Y. 1984. HLA antigens in Japanese patients with narcolepsy. All the patients were DR2 positive. Tissue Antigens 24, 316 319.
34. Kanbayashi, T., Inoue, Y., Chiba, S., Aizawa, R., Saito, Y., Tsukamoto, H., Fujii, Y., Nishino, S. Shimizu, T. 2002. CSF hypocretin-1 (orexin-A) concentrations in narcolepsy with and without cataplexy and idiopathic hypersomnia. J Sleep Res 11, 91 93.
35. Kanbayashi, T., Shimohata, T., Nakashima, I., Yaguchi, H., Yabe, I., Shimizu, T. Nishino, S. 2009. Symptomatic narcolepsy in MS and NMO patients; new neurochemical and immunological implications. Arch Neurol (in press).
36. Kato, T., Kanbayashi, T., Yamamoto, K., Nakano, T., Shimizu, T., Hashimoto, T. Ikeda, S. 2003. Hypersomnia and low CSF hypocretin-1 (orexin-A) concentration in a patient with multiple sclerosis showing bilateral hypothalamic lesions. Intern Med 42, 743 745.
37. Kawashima, M., Tamiya, G., Oka, A., Hohjoh, H., Juji, T., Ebisawa, T., Honda, Y., Inoko, H. Tokunaga, K. 2006. Genomewide association analysis of human narcolepsy and a new resistance gene. Am J Hum Genet 79, 252 263.
38. Lennon, V.A., Kryzer, T.J., Pittock, S.J., Verkman, A.S. Hinson, S.R. 2005. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 202, 473 477.
39. Lhermitte, J. Roques, A.A. 1928. Narcolepsie et cataplexie post-encephalitiques. Rev Neurol II, 264 267.
40. Lieberman, A.P., Pitha, P.M., Shin, H.S. Shin, M.L. 1989. Production of tumor necrosis factor and other cytokines by astrocytes stimulated with lipopolysaccharide or a neurotropic virus. Proc Natl Acad Sci U S A 86, 6348 6352.
41. Lin, L., Faraco, J., Li, R., Kadotani, H., Rogers, W., Lin, X., Qiu, X., de Jong, P.J., Nishino, S. Mignot, E. 1999. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell 98, 365 376.
42. Liu, M., Thankachan, S., Kaur, S., Begum, S., Blanco-Centurion, C., Sakurai, T., Yanagisawa, M., Neve, R. Shiromani, P. J. 2008. Orexin (hypocretin) gene transfer diminishes narcoleptic sleep behavior in mice. Eur J Neurosci 28, 1382 1393.
43. Mamelak, M. 1992. A perspective on narcolepsy. Encephale 18, 347 351.
44. Marcus, C.L., Trescher, W.H., Halbower, A.C. Lutz, J. 2002. Secondary narcolepsy in children with brain tumors. Sleep 25, 435 439.
45. Matsuki, K., Juji, T. Honda, Y. 1988. Immunological features of narcolepsy in Japan. In : Y. Honda T. Juji (eds) HLA in Narcolepsy. Springer-Verlag, New York. pp. 150 157.
46. Mieda, M., Willie, J.T., Hara, J., Sinton, C.M., Sakurai, T. Yanagisawa, M. 2004. Orexin peptides prevent cataplexy and improve wakefulness in an orexin neuron-ablated model of narcolepsy in mice. Proc Natl Acad Sci USA 101, 4649 4654.
47. Mignot, E. 1998. Genetic and familial aspects of narcolepsy. Neurology 50, S16 S22.
48. Mignot, E., Guilleminault, C., Grumet, F.C. Dement, W.C. 1992. Is narcolepsy an autoimmune disease? In : S. Smirne, M. Francesci, L. Ferini-Strambi M. Zucconi (eds) Proceedings of the Third Milano International Symposium, 18-19 September "Sleep, Hormones, and the Immune System". 1992. Masson, Milan. pp. 29 38.
49. Mignot, E., Hayduk, R., Grumet, F.C., Black, J. Guilleminault, C. 1997. HLA DQB1*0602 is associated with cataplexy in 509 narcoleptic patients. Sleep 20, 1012 1020. (Pubitemid 28042450)
50. Mignot, E., Lammers, G.J., Ripley, B., Okun, M., Nevsimalova, S., Overeem, S., Vankova, J., Black, J., Harsh, J., Bassetti, C., Schrader, H. Nishino, S. 2002. The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias. Arch Neurol 59, 1553 1562.
51. Mishima, K., Fujiki, N., Yoshida, Y., Sakurai, T., Honda, M., Mignot, E. Nishino, S. 2008. Hypocretin receptor expression in canine and murine narcolepsy models and in hypocretin-ligand deficient human narcolepsy. Sleep 31, 1119 1126.
52. Miyagawa, T., Kawashima, M., Nishida, N., Ohashi, J., Kimura, R., Fujimoto, A., Shimada, M., Morishita, S., Shigeta, T., Lin, L. et al. 2008. Variant between CPT1B and CHKB associated with susceptibility to narcolepsy. Nat Genet 40, 1324 1328.
53. Montplaisir, J., Poirier, G., Lapierre, O. Montplaisir, S. 1989. Streptococcal antibodies in Narcolepsy and idiopathic hypersomnia. Sleep Res 18, 271.
54. Nakamura, M., Nishii, M., Maki, S., Nakamuara, M. Suenaga, T. 2005. A MS cases with EDS and bilateral hypothalamic lesions. Clin Neurol 45, 187 (in Japanese).
55. Nishino, S. 2003. The hypocretin/orexin system in health and disease. Biol Psychiatry 54, 87 95.
56. Nishino, S. 2007. Clinical and neurobiological aspects of narcolepsy. Sleep Med 8, 373 399.
57. Nishino, S. Kanbayashi, T. 2005. Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system. Sleep Med Rev 9, 269 310.
58. Nishino, S. Mignot, E. 1997. Pharmacological aspects of human and canine narcolepsy. Prog Neurobiol 52, 27 78.
59. Nishino, S., Riehl, J., Hong, J., Kwan, M., Reid, M. Mignot, E. 2000a. Is narcolepsy REM sleep disorder? Analysis of sleep abnormalities in narcoleptic Dobermans. Neurosci Res 38, 437 446.
60. Nishino, S., Ripley, B., Overeem, S., Lammers, G. Mignot, E. 2000b. Hypocretin (orexin) deficiency in human narcolepsy. Lancet 355, 39 40.
61. Nishino, S., Ripley, B., Overeem, S., Nevsimalova, S., Lammers, G.J., Vankova, J., Okun, M., Rogers, W., Brooks, S. Mignot, E. 2001. Low CSF hypocretin (orexin) and altered energy homeostasis in human narcolepsy. Ann Neurol 50, 381 388. (Pubitemid 32848741)
62. Nishino, S., Kanbayashi, T., Fujiki, N., Uchino, M., Ripley, B., Watanabe, M., Lammers, G.J., Ishiguro, H., Shoji, S., Nishida, Y. et al. 2003. CSF hypocretin levels in Guillain-Barre syndrome and other inflammatory neuropathies. Neurology 61, 823 825.
63. Nishino, S., Taheri, S., Black, J., Nofzinger, E. Mignot, E. 2004. The neurobiology of sleep in relation to mental illness. In : D.S. Charney E.J. Nestler (ed.) Neurobiology of Mental Illness. Oxford University Press, New York. pp. 1160 1179.
64. Nozaki, H., Shimohata, T., Kanbayashi, T., Sagawa, Y., Katada, S.I., Satoh, M., Onodera, O., Tanaka, K. Nishizawa, M. 2008. A patient with anti-aquaporin 4 antibody who presented with recurrent hypersomnia, reduced orexin (hypocretin) level, and symmetrical hypothalamic lesions. Sleep Med 10, 253 255.
65. Oka, Y., Kanbayashi, T., Mezaki, T., Iseki, K., Matsubayashi, J., Murakami, G., Matsui, M., Shimizu, T. Shibasaki, H. 2004. Low CSF hypocretin-1/orexin-A associated with hypersomnia secondary to hypothalamic lesion in a case of multiple sclerosis. J Neurol 251, 885 886.
66. Overeem, S., Dalmau, J., Bataller, L., Nishino, S., Mignot, E., Vershuuren, J. Lammers, G.J. 2001. Secondary narcolepsy in patients with praneoplastic anti-Ma2 antibodies is associated with hypocretin deficiency. J Sleep Res 11 (Suppl. 1 166 167.
67. Park, M.H., Roh, E.Y., Park, H., Kim, S.J. Jeong, D.U. 2004. Association of TNF-alpha gene promoter polymorphism with narcolepsy-cataplexy in Koreans. Hum Immunol 65, S110.
68. Peyron, C., Tighe, D.K., van den Pol, A.N., de Lecea, L., Heller, H.C., Sutcliffe, J.G. Kilduff, T.S. 1998. Neurons containing hypocretin (orexin) project to multiple neuronal systems. J Neurosci 18, 9996 10015.
69. Peyron, C., Faraco, J., Rogers, W., Ripley, B., Overeem, S., Charnay, Y., Nevsimalova, S., Aldrich, M., Reynolds, D., Albin, R. et al. 2000a. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med 6, 991 997.
70. Peyron, C., Faraco, J., Rogers, W., Ripley, B., Overeem, S., Charnay, Y., Nevsimalova, S., Aldrich, M., Reynolds, D., Albin, R. et al. 2000b. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med 6, 991 997.
71. Pittock, S.J., Weinshenker, B.G., Lucchinetti, C.F., Wingerchuk, D.M., Corboy, J.R. Lennon, V.A. 2006. Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression. Arch Neurol 63, 964 968.
72. Poirier, G., Montplaisir, J., Dumont, M., Duquette, P., Decary, F., Pleines, J. Lamoureux, G. 1987. Clinical and sleep laboratory study of narcoleptic symptoms in multiple sclerosis. Neurology 37, 693 695.
73. Rao, K.V. Qureshi, I.A. 1997. Decompensation of hepatic and cerebral acyl-CoA metabolism in BALB/cByJ mice by chronic riboflavin deficiency: restoration by acetyl-L-carnitine. Can J Physiol Pharmacol 75, 423 430.
74. Ripley, B., Fujiki, N., Okura, M., Mignot, E. Nishino, S. 2001a. Hypocretin levels in sporadic and familial cases of canine narcolepsy. Neurobiol Dis 8, 525 534. (Pubitemid 32566142)
75. Ripley, B., Overeem, S., Fujiki, N., Nevsimalova, S., Uchino, M., Yesavage, J., Di Monte, D., Dohi, K., Melberg, A., Lammers, G.J., Nishida, Y., Roelandse, F.W., Hungs, M., Mignot, E. Nishino, S. 2001b. CSF hypocretin/orexin levels in narcolepsy and other neurological conditions. Neurology 57, 2253 2258.
76. Sakurai, T., Amemiya, A., Ishii, M., Matsuzaki, I., Chemelli, R.M., Tanaka, H., Williams, S.C., Richardson, J.A., Kozlowski, G.P., Wilson, S. et al. 1998. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 92, 573 585.
77. Saper, C.B., Scammell, T.E. Lu, J. 2005. Hypothalamic regulation of sleep and circadian rhythms. Nature 437, 1257 1263. (Pubitemid 41568665)
78. Scammell, T.E. 2006. The frustrating and mostly fruitless search for an autoimmune cause of narcolepsy. Sleep 29, 601 602.
79. Scammell, T., Nishino, S., Mignot, E. Saper, C. 2001. Narcolepsy and low CSF orexin (hypocretin) concentration after a diencephalic stroke. Neurology 56, 1751 1753. (Pubitemid 32574580)
80. Schatzberg, S.J., Barrett, J., Cutter, K.L., Ling, L. Mignot, E. 2004. Case study: effect of hypocretin replacement therapy in a 3-year-old Weimaraner with narcolepsy. J Vet Internal Med 18, 586 588.
81. Siegel, J. 2000. Brainstem mechanisms generating REM sleep. In : M.H. Kryger, T. Rohr W.C. Dement (eds) Principles and Practice of Sleep Medicine, 3rd edn. W.B. Saunders Company, Philadelphia, PA. pp. 112 133.
82. Smith, C. Hamilton, J. 1959. Psychological factors in the narcolepsy-cataplexy syndrome. Psychosom Med 21, 40 49.
83. Stiefler, G. 1924. Narkolepsie nach enzephalitis lethargica. Wien Klin 37, 1044 1046.
84. Tachibana, N., Howard, R.S., Hirsch, N.P., Miller, D.H., Moseley, I.F. Fish, D. 1994. Sleep problems in multiple sclerosis. Eur Neurol 34, 320 323.
85. Tafti, M., Petit, B., Chollet, D., Neidhart, E., de Bilbao, F., Kiss, J.Z., Wood, P.A. Franken, P. 2003. Deficiency in short-chain fatty acid beta-oxidation affects theta oscillations during sleep. Nat Genet 34, 320 325.
86. Takeuchi, T., Miyasita, A., Sasaki, Y., Inugami, M. Fukuda, K. 1992. Isolated sleep paralysis elicited by sleep interruption. Sleep 15, 217 225.
87. Thannickal, T., Moore, R., Nienhuis, R., Ramanathan, L., Gulyani, S., Aldrich, M., Cornford, M. Siegel, J. 2000a. Reduced number of hypocretin neurons in human narcolepsy. Neuron 27, 469 474.
88. Verma, A., Anand, V. Verma, N.P. 2007. Sleep disorders in chronic traumatic brain injury. J Clin Sleep Med 3, 357 362.
89. Wieczorek, S., Gencik, M., Rujescu, D., Tonn, P., Giegling, I., Epplen, J.T. Dahmen, N. 2003. TNFA promoter polymorphisms and narcolepsy. Tissue Antigens 61, 437 442.